GT Biopharma, Inc.
GTBP
$5.98
$0.7414.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.96M | 8.92M | 6.81M | 2.53M | 5.23M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 227.00K | 409.00K | 567.00K | 940.00K | 1.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 601.00K | 664.00K | 728.00K | 853.00K | 853.00K |
| Total Current Assets | 5.79M | 10.00M | 8.11M | 4.32M | 7.12M |
|
|
|||||
| Total Current Assets | 5.79M | 10.00M | 8.11M | 4.32M | 7.12M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.79M | 10.00M | 8.11M | 4.32M | 7.12M |
|
|
|||||
| Total Accounts Payable | 1.02M | 253.00K | 748.00K | 769.00K | 1.37M |
| Total Accrued Expenses | 1.20M | 2.16M | 1.56M | 400.00K | 608.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 11.00K | 152.00K | 325.00K |
| Total Other Current Liabilities | -- | -- | 11.00K | 152.00K | 325.00K |
| Total Current Liabilities | 2.22M | 2.42M | 2.32M | 1.32M | 2.31M |
|
|
|||||
| Total Current Liabilities | 2.22M | 2.42M | 2.32M | 1.32M | 2.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.22M | 2.42M | 2.32M | 1.32M | 2.31M |
|
|
|||||
| Common Stock & APIC | 735.00M | 734.42M | 729.69M | 703.78M | 700.38M |
| Retained Earnings | -731.43M | -726.84M | -723.90M | -700.78M | -697.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.57M | 7.58M | 5.79M | 3.00M | 2.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.96M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.96M |
|
|
|||||
| Total Common Equity | 3.57M | 7.58M | 5.79M | 3.00M | 2.86M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.96M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.57M | 7.58M | 5.79M | 3.00M | 4.82M |
|
|
|||||